2022 - Research.com Best Scientist Award
2022 - Research.com Medicine in Thailand Leader Award
2022 - Research.com Microbiology in Thailand Leader Award
2002 - Chalmers Medal, Royal Society of Tropical Medicine and Hygiene
François Nosten mainly focuses on Malaria, Plasmodium falciparum, Artesunate, Artemisinin and Mefloquine. His Malaria study combines topics in areas such as Pregnancy, Internal medicine and Pharmacology. His study in Internal medicine is interdisciplinary in nature, drawing from both Gastroenterology and Surgery.
His Plasmodium falciparum research incorporates elements of Genetics, Drug resistance, Environmental health and Virology. The Artesunate study which covers Artemether that intersects with Lumefantrine. His Mefloquine research incorporates themes from Quinine, Gametocyte, Sulfadoxine and Multiple drug resistance.
François Nosten spends much of his time researching Malaria, Plasmodium falciparum, Plasmodium vivax, Pregnancy and Virology. His Malaria research is multidisciplinary, incorporating elements of Internal medicine and Pharmacology. François Nosten combines subjects such as Quinine and Genetics, Drug resistance with his study of Plasmodium falciparum.
He focuses mostly in the field of Plasmodium vivax, narrowing it down to matters related to Primaquine and, in some cases, Haemolysis. His Pregnancy research is multidisciplinary, relying on both Pediatrics and Obstetrics. His Virology study combines topics from a wide range of disciplines, such as Plasmodium, Antibody and Antigen.
His primary scientific interests are in Malaria, Plasmodium falciparum, Plasmodium vivax, Virology and Primaquine. His Malaria study integrates concerns from other disciplines, such as Pregnancy, Clinical trial and Cohort study. His Pregnancy research is multidisciplinary, incorporating perspectives in Quinine, Lumefantrine and Cohort.
His research in the fields of Artemisinin overlaps with other disciplines such as Southeast asian. His work on Transmission as part of general Virology study is frequently linked to Low transmission, bridging the gap between disciplines. In his study, Chloroquine and Dihydroartemisinin/piperaquine is inextricably linked to Internal medicine, which falls within the broad field of Primaquine.
His primary areas of investigation include Malaria, Plasmodium falciparum, Primaquine, Internal medicine and Plasmodium vivax. He works in the field of Malaria, focusing on Plasmodium in particular. Many of his research projects under Plasmodium falciparum are closely connected to Southeast asian with Southeast asian, tying the diverse disciplines of science together.
The study incorporates disciplines such as Gastroenterology, Glucose-6-phosphate dehydrogenase deficiency and Haemolysis in addition to Primaquine. The various areas that François Nosten examines in his Internal medicine study include Artemether, Artemether/lumefantrine and Lumefantrine. His study looks at the relationship between Plasmodium vivax and topics such as Dihydroartemisinin/piperaquine, which overlap with Regimen.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Artemisinin Resistance in Plasmodium falciparum Malaria
Arjen M. Dondorp;François Nosten;Poravuth Yi;Debashish Das.
The New England Journal of Medicine (2009)
Spread of Artemisinin Resistance in Plasmodium falciparum Malaria
Ashley Ea;Dhorda M;Fairhurst Rm;Amaratunga C.
The New England Journal of Medicine (2014)
Epidemiology and burden of malaria in pregnancy
Meghna Desai;Feiko O ter Kuile;Feiko O ter Kuile;François Nosten;François Nosten;Rose McGready;Rose McGready.
Lancet Infectious Diseases (2007)
Spiroindolones, a Potent Compound Class for the Treatment of Malaria
Matthias Rottmann;Matthias Rottmann;Case McNamara;Bryan K.S. Yeung;Marcus C.S. Lee.
Science (2010)
Artesunate versus quinine for treatment of severe falciparum malaria: a randomised trial.
Arjen M. Dondorp;Francois Nosten;Kasia Stepniewska;Nicholas P. J. Day.
The Lancet (2005)
Mefloquine resistance in Plasmodium falciparum and increased pfmdr1 gene copy number.
Ric N. Price;Ric N. Price;Anne Catrin Uhlemann;Alan Brockman;Rose McGready.
The Lancet (2004)
Emergence of artemisinin-resistant malaria on the western border of Thailand: a longitudinal study
Aung Pyae Phyo;Standwell Nkhoma;Kasia Stepniewska;Kasia Stepniewska;Elizabeth A. Ashley;Elizabeth A. Ashley.
The Lancet (2012)
Microsatellite Markers Reveal a Spectrum of Population Structures in the Malaria Parasite Plasmodium falciparum
Timothy J. C. Anderson;Bernhard Haubold;Jeff T. Williams;Jose G. Estrada-Franco§.
Molecular Biology and Evolution (2000)
Maternal antibodies block malaria.
Michal Fried;François Nosten;François Nosten;Alan Brockman;Alan Brockman;Bernard J. Brabin.
Nature (1998)
Artemisinin-based combination treatment of falciparum malaria.
François Nosten;Nicholas J. White.
American Journal of Tropical Medicine and Hygiene (2007)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:
Mahidol University
Mahidol University
University of Oxford
University of Oxford
Charles Darwin University
Mahidol Oxford Tropical Medicine Research Unit
Mahidol University
University of Otago
University of Oxford
Nanyang Technological University
University of Ljubljana
Paris-Est Créteil University
University of Bonn
Delft University of Technology
Soochow University
Universität Hamburg
Université Laval
University of Maryland, College Park
University of Amsterdam
Iowa State University
United States Geological Survey
University of Liège
University of Iowa
Roswell Park Cancer Institute
Columbia University
University of Manchester